Invasive mucinous adenocarcinoma (IMA) is a newly classified variant of lung
adenocarcinoma. The aim of this study was to examine the correlation between the …

In 2015 a new WHO classification of lung tumors was issued. This classification clarified
several important issues and corrected many entities (1). For adenocarcinomas the previous …

Invasive mucinous adenocarcinoma (IMA), which is a relatively rare lung adenocarcinoma,
is considered a high‐grade subtype and is associated with a poor prognosis. IMA is difficult …

Primary pulmonary mucinous adenocarcinoma is an unusual histological type of non-small
cell lung cancer and has a rare prevalence at a young age. There is no standard first-line …

Invasive mucinous adenocarcinoma (IMA), formerly referred to as mucinous
bronchioloalveolar carcinoma, is a rare variant form of invasive adenocarcinoma and is …

To investigate the epidemiology, demographics and survival of mucinous adenocarcinomas
(MACs), we identified 80,758 MAC patients in the Surveillance, Epidemiology and End …

Background Invasive mucinous adenocarcinoma (IMA) comprises~ 5% of lung
adenocarcinoma. There is no effective therapy for IMA when surgical resection is not …

Pulmonary invasive mucinous adenocarcinoma (PIMA) formerly known as mucinous
bronchioalveolar carcinoma is a relatively rare variant of pulmonary adenocarcinoma, but …

Purpose: Invasive mucinous adenocarcinoma (IMA) is a unique subtype of lung
adenocarcinoma, characterized genomically by frequent KRAS mutations or specific gene …

This is a brief case report of invasive multicentric mucinous adenocarcinoma presented at a
rather young age with bronchorrhea and persistent consolidation that ended up with the …